Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 24 July 2019. Maham Ansari.

Executive Summary

Pakistan's health-care market is set to be unlocked when new medtech regulations are placed this year. See what Maham Ansari, director of regulatory affairs at Synaptive Medical, said about Pakistan's medtech regulations at the recent Knecht 365, Informa's MedTech Summit, here.

“But if you don’t file before that time, you will be locked out of the market. Companies could then have to wait up to three years for medical device approvals, with serious implications for business continuity." Maham Ansari, director regulatory affairs, Synaptive Medical

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel